Xuejun Li Selected Research

PERK kinase

10/2019

Preconditioning with endoplasmic reticulum stress alleviated heart ischemia/reperfusion injury via modulating IRE1/ATF6/RACK1/PERK and PGC-1α in diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuejun Li Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 09/2010
18	Glioma (Gliomas) 01/2022 - 01/2014
10	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2013
9	Inflammation (Inflammations) 02/2022 - 04/2010
9	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 08/2013
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2015
8	Infections 06/2022 - 12/2014
8	Ischemia 10/2019 - 01/2008
7	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 06/2012
7	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 08/2014
7	Insulin Resistance 05/2020 - 01/2013
6	Obesity 01/2022 - 02/2016
6	Body Weight (Weight, Body) 01/2021 - 11/2006
6	Hypoxia (Hypoxemia) 11/2020 - 01/2008
5	Wounds and Injuries (Trauma) 03/2022 - 01/2013
5	Lung Neoplasms (Lung Cancer) 01/2015 - 02/2012
4	Pain (Aches) 03/2022 - 01/2014
4	Carcinogenesis 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 12/2016 - 10/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 02/2012
3	Reperfusion Injury 02/2022 - 01/2018
3	Disease Resistance 02/2022 - 12/2014
3	Hypertension (High Blood Pressure) 12/2021 - 01/2014
3	Chronic Hepatitis B 10/2021 - 01/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2013
3	Obstructive Sleep Apnea 12/2020 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2012
3	Brain Neoplasms (Brain Tumor) 01/2020 - 10/2011
3	Cysts 01/2019 - 03/2011
3	Adenocarcinoma of Lung 01/2018 - 06/2008
3	Carcinoma (Carcinomatosis) 03/2016 - 05/2012
2	Fibrosis (Cirrhosis) 04/2022 - 09/2002
2	Disease Progression 01/2022 - 09/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2015
2	Acute-On-Chronic Liver Failure 08/2021 - 01/2021
2	Graves Disease (Basedow Disease) 01/2021 - 04/2010
2	Atherosclerosis 05/2020 - 06/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2018
2	Medulloblastoma 01/2020 - 01/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2020 - 10/2017
2	Breast Neoplasms (Breast Cancer) 10/2019 - 02/2019
2	Stroke (Strokes) 01/2019 - 03/2010
2	Adenoma (Adenomas) 01/2019 - 12/2018
2	Glucose Intolerance 07/2018 - 01/2018
2	Hyperglycemia 07/2018 - 01/2018
2	Esophageal Squamous Cell Carcinoma 02/2018 - 01/2017
2	Hyperthyroidism 01/2018 - 10/2015
2	Insulinoma 01/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2008
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2008
10	Pharmaceutical PreparationsIBA 03/2022 - 03/2011
10	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2010
10	Insulin (Novolin)FDA Link 01/2022 - 01/2016
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
5	LipidsIBA 12/2020 - 01/2013
5	Fetuin-BIBA 05/2020 - 12/2017
5	CurcuminIBA 01/2020 - 03/2011
5	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2010
4	ORALIT (ORS)IBA 01/2020 - 02/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 02/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2012
4	Uric Acid (Urate)IBA 01/2019 - 12/2016
4	Triglycerides (Triacylglycerol)IBA 07/2018 - 01/2016
4	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2017 - 08/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 01/2012
3	Biological ProductsIBA 03/2021 - 01/2019
3	ParaffinIBA 01/2020 - 09/2010
3	Oxygen (Dioxygen)IBA 09/2019 - 01/2008
3	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 01/2017
3	HDL CholesterolIBA 01/2018 - 12/2012
3	LDL CholesterolIBA 01/2018 - 12/2012
3	Alanine Transaminase (SGPT)IBA 01/2018 - 10/2015
3	puerarinIBA 01/2018 - 01/2014
3	CytokinesIBA 05/2017 - 04/2010
3	Atorvastatin (Lipitor)FDA Link 05/2012 - 02/2012
2	Therapeutic UsesIBA 01/2021 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2017
2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 03/2020 - 01/2013
2	Formaldehyde (Formol)FDA Link 01/2020 - 09/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 10/2019
2	Ion Channels (Ion Channel)IBA 01/2020 - 11/2018
2	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2019 - 06/2015
2	Hormones (Hormone)IBA 12/2019 - 06/2015
2	ErbB Receptors (EGF Receptor)IBA 11/2019 - 01/2015
2	Caspase 3 (Caspase-3)IBA 10/2019 - 01/2018
2	Apoptosis Regulatory ProteinsIBA 10/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 11/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 11/2011
2	CateninsIBA 01/2019 - 01/2017
2	Dynamins (Dynamin)IBA 07/2018 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 10/2017

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2013
9	Drug Therapy (Chemotherapy) 08/2019 - 05/2012
8	Radiotherapy 01/2022 - 06/2012
2	Immunotherapy 01/2022 - 01/2021
2	Transplantation 11/2021 - 08/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2013
2	Chemoradiotherapy 01/2019 - 09/2017
2	Adjuvant Radiotherapy 01/2018 - 08/2014